TRT Side Effects 2026: Risks & How to Manage Them

The most common TRT side effects are elevated red blood cell count (polycythemia), testicular atrophy, and acne — all dose-dependent and manageable with proper monitoring. Most men who discontinue testosterone replacement therapy do so not because of side effects, but because they were unprepared for the monitoring requirements that keep treatment safe. This guide covers every clinically relevant TRT side effect, the warning threshold for each, and what a responsible online TRT clinic should do before problems escalate.

Independently researched · Updated July 2026 · Affiliate disclosure

Why TRT produces side effects: the mechanism behind each one

Testosterone replacement therapy works by introducing exogenous (externally supplied) testosterone into your bloodstream, bypassing the hypothalamic-pituitary-testicular (HPT) axis that normally regulates hormone production. This shortcut is medically necessary for men with confirmed hypogonadism — but it has consequences the body's own feedback loop would normally prevent.

Understanding the underlying biology makes TRT side effects predictable rather than alarming. Three central mechanisms drive the majority of TRT side effects:

1. Androgen receptor stimulation in off-target tissues. Testosterone binds to receptors not only in muscle and bone, but in sebaceous glands (acne), prostate cells (PSA elevation), scalp follicles (DHT-driven hair loss), and hematopoietic stem cells (red blood cell overproduction).
2. Aromatization to estradiol. The enzyme aromatase converts a fraction of testosterone to estrogen. When T levels are supraphysiologic — even briefly — estradiol rises, potentially causing gynecomastia or water retention.
3. HPT axis suppression. The brain detects elevated circulating testosterone and stops signaling the testes to produce their own — causing testicular atrophy and eliminating natural sperm production for as long as treatment continues.

Understanding these mechanisms helps you ask the right questions at intake and recognize early warning signs before they escalate.

The six most common TRT side effects — and how they are managed

The following table shows prevalence estimates from published clinical data and the standard-of-care response for each side effect. References to "monitoring" mean routine lab work — the cornerstone of responsible TRT management.

Elevated hematocrit (polycythemia)

Hematocrit is the most clinically significant dose-dependent TRT side effect. Testosterone stimulates erythropoietin secretion, which increases red blood cell production. Higher hematocrit raises blood viscosity — thickening the blood — and elevates risk of deep vein thrombosis, pulmonary embolism, and stroke if hematocrit climbs above 54% on repeated draws.

Injectable testosterone produces higher peak-to-trough T levels than cream or oral formulations, which means injectable TRT carries a meaningfully higher risk of polycythemia than daily-applied cream or FDA-approved oral capsules (Kyzatrex). The American Heart Association's 2024 Scientific Statement on testosterone therapy notes that routine hematocrit monitoring — at baseline, 3 months, and every 6 months thereafter — is non-negotiable for patient safety.

What a good clinic does: Orders a complete blood count (CBC) at baseline and at each follow-up. Any hematocrit above 50% triggers a phone or portal consultation; above 54%, dosing stops or is reduced until levels normalize. Some clinics offer therapeutic phlebotomy coordination.

Testicular atrophy

When exogenous testosterone enters the bloodstream, the hypothalamus and pituitary detect the elevated levels and stop releasing LH (luteinizing hormone) and FSH (follicle-stimulating hormone) — the signals that tell the testes to produce testosterone and sperm. Without LH and FSH, the testes lose stimulation, reduce activity, and progressively decrease in volume — a predictable TRT side effect occurring in the majority of men on injectable protocols.

Atrophy is not painful and is reversible for most men after discontinuation, but sperm count recovery can take 3–12 months (or longer with longer treatment duration). If you have not yet completed your family, this is the single most important conversation to have before starting TRT. Human chorionic gonadotropin (HCG) mimics LH and can maintain testicular volume and partial sperm production while on TRT; some clinics include it as a standard add-on.

Acne and oily skin

Androgens stimulate sebaceous (oil) gland activity — the same pathway that drives adolescent acne during the testosterone surge of puberty. TRT can reactivate this process in adult men, particularly on the back, chest, and face. This TRT side effect is more common at higher dose ranges and during the first months of titration when T levels fluctuate more widely.

Most cases are mild and resolve within 6–12 months as the body adjusts. Topical benzoyl peroxide or retinoids are the first-line response. Severe nodulo-cystic acne is rare and warrants a dose adjustment or modality switch.

Gynecomastia

As testosterone levels rise, aromatase converts a fraction to estradiol. If estradiol climbs disproportionately, the estrogen-to-androgen ratio shifts in breast tissue — triggering glandular growth. This TRT side effect presents as a firm, rubbery nodule under one or both nipples, sometimes tender to pressure. It is distinct from chest fat (lipomastia) and does not resolve with weight loss; glandular gynecomastia requires medical management.

First-line treatment is an aromatase inhibitor (AI) — anastrozole (Arimidex) is most commonly prescribed — which blocks estradiol production without affecting testosterone. Monitoring estradiol at 3-month intervals prevents this TRT side effect from progressing. The target estradiol range on TRT is typically 20–40 pg/mL.

TRT side effects on fertility — what you must know before starting

Testosterone replacement therapy is a highly effective (if unintended) male contraceptive. By suppressing LH and FSH, TRT shuts down spermatogenesis in the vast majority of men within weeks to months of initiating treatment. A semen analysis showing essentially zero sperm count is normal on TRT — it does not mean permanent infertility.

In most men, sperm production recovers after discontinuation. A 2020 meta-analysis published in Fertility and Sterility found that 67% of men recovered to pre-treatment sperm counts within 6 months after stopping TRT, and 90% within 24 months. However, recovery is not guaranteed, particularly for men who used TRT for more than five years, used supraphysiologic doses, or had underlying testicular dysfunction before starting.

If you are actively trying to conceive or planning to within the next two years, discuss three options with your clinician before starting TRT:

1. Enclomiphene or clomiphene — stimulates natural LH/FSH; raises testosterone without suppressing sperm production. The fertility-preserving alternative to TRT.
2. HCG co-administration — maintains testicular function during TRT. Adds cost but preserves sperm production and testicular volume.
3. Sperm banking — a one-time precaution before initiating TRT for men who want an insurance policy.

See the enclomiphene discussion in our MangoRx Review — MangoRx includes enclomiphene in several of its plans and is one of the few online clinics offering it alongside injectable and oral testosterone options.

TRT and cardiovascular risk: what the evidence actually says

Cardiovascular risk has been the most debated TRT side effect since the FDA added a boxed warning to testosterone products in 2015, citing concern about elevated cardiovascular event rates in observational studies. That picture has materially changed.

The TRAVERSE trial (2023) — the largest randomized controlled trial of TRT conducted to date, enrolling 5,246 men aged 45–80 with confirmed low testosterone and elevated cardiovascular risk — found that testosterone therapy was non-inferior to placebo for major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) over a median 33 months of follow-up. The results were published in The New England Journal of Medicine.

Based on this and follow-on regulatory review, the FDA updated the testosterone label in June 2026, removing language that had overstated cardiovascular risk for men with age-related hypogonadism. The regulatory update also matters for the ongoing testosterone shortage conversation — streamlined prescribing pathways are expanding access to alternative formulations like oral Kyzatrex.

Important nuance: The TRAVERSE trial excluded men with hematocrit above 48% at baseline. Polycythemia — the hematocrit-elevation TRT side effect described above — is a legitimate cardiovascular risk that requires monitoring and management. The cardiovascular risk of TRT is largely mediated through uncontrolled hematocrit, not through testosterone itself. This is why monitoring matters more than the drug choice.

TRT and prostate health

TRT does not cause prostate cancer. The "androgen saturation" model proposed by Abraham Morgentaler and colleagues in the early 2000s — supported by several large-scale trials since — shows that testosterone does not increase prostate cancer incidence in men with confirmed hypogonadism and no active or recent prostate cancer.

However, TRT can stimulate the growth of an existing undiagnosed prostate cancer — making pre-treatment PSA screening mandatory. The clinical standard:

• PSA baseline before initiating TRT.
• PSA at 3 and 12 months, then annually.
• A rapid PSA rise of more than 1.4 ng/mL in the first 12 months, or any level above 4.0 ng/mL, triggers urology referral.

Men with active prostate cancer or a history of prostate cancer should not use TRT without specialist oncology review. Men with benign prostatic hyperplasia (BPH) on TRT typically see no significant worsening of urinary symptoms at physiologic doses.

TRT and hair loss: the DHT connection

Hair loss is one of the most feared TRT side effects, but it is real only for genetically susceptible men. Testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5-alpha reductase — particularly in the scalp and prostate. DHT is the primary driver of male pattern baldness (androgenic alopecia). For men with a family history of male pattern baldness, TRT can accelerate the process; for men without genetic susceptibility, TRT-related hair loss is unlikely.

Finasteride or dutasteride (5-alpha reductase inhibitors) can block DHT conversion and are used by some men on TRT who experience hair thinning. However, they also reduce prostate PSA readings (masking PSA surveillance data) and carry their own side effects; their use alongside TRT requires clinician oversight.

How a good online TRT clinic monitors for side effects

Monitoring is what separates responsible TRT from the "testosterone mills" that prescribe without follow-up. Most serious TRT side effects are preventable — not by avoiding the therapy, but by catching early lab signals before they become clinical problems. Any clinic operating within the legal and ethical standard of care should provide the following monitoring schedule:

Clinics that skip baseline PSA, offer no estradiol monitoring, or don't check hematocrit at three months should be avoided regardless of price.

Which online TRT clinics have the best side-effect monitoring?

The depth of monitoring varies significantly across online TRT providers. Here is how our partnered clinics compare on the variables that affect safety:

Prices verified June 2026. First-month costs at Peter MD may include a one-time evaluation fee of $99–149; see the full Peter MD cost breakdown for details.

Male Excel scores 9.0/10 on our clinical monitoring rubric — the highest among mid-range clinics — and provides needle-free daily cream TRT at $149/mo with labs included. For men whose primary concern is managing TRT side effects through rigorous follow-up, Male Excel's monitoring protocol is difficult to beat at this price point.

Try Ageless (tryageless.com) bundles anastrozole into the base Complete plan at $129/mo — the only clinic in our comparison set that includes the aromatase inhibitor without an add-on fee. Their four modality options (injectable, topical, cream, oral tablet) also allow switching if one formulation produces disproportionate hematocrit elevation.

Visit Male Excel — Clinical-Grade TRT Monitoring from $149/mo →

Visit Try Ageless — Anastrozole Included, 4 TRT Modalities →

Frequently asked questions about TRT side effects

What are the first TRT side effects men notice? The earliest commonly reported effects — appearing within 2–6 weeks of starting — are acne or oily skin (particularly on the back and chest), increased libido, and some water retention. Testicular atrophy typically becomes noticeable within 4–8 weeks on injectable TRT. Hematocrit changes accumulate over months, which is why the 3-month CBC check is critical.

Do TRT side effects go away if you stop? Most do. Hematocrit returns to baseline within weeks to months of discontinuation. Acne typically clears. Estradiol normalizes as exogenous testosterone clears. Testicular atrophy partially or fully reverses in most men, though sperm count recovery can take 6–24 months. Hair loss driven by DHT is the exception — follicle miniaturization is partially irreversible in genetically susceptible men.

Is hematocrit elevation dangerous, and how common is it? Hematocrit above 54% is clinically significant and requires intervention — either a dose reduction or therapeutic phlebotomy (blood donation). Reported prevalence ranges from 3% (cream/gel formulations) to 18% (injectable, especially depot injections with long intervals). The risk is lower with daily-application modalities (cream, oral capsule) that avoid high peak levels; higher with weekly or biweekly injections that produce large T swings. Any clinic that doesn't order a CBC at 3 months is not managing this risk appropriately.

Does TRT shorten your life? Current evidence says no for men with confirmed hypogonadism. The TRAVERSE trial (2023) found no increase in cardiovascular mortality versus placebo over 33 months in high-risk men. Observational studies in large population databases have found lower all-cause mortality in hypogonadal men who received TRT versus those who did not. Unmanaged polycythemia is the primary mechanism by which poorly supervised TRT could shorten life; proper monitoring removes that risk.

What's the difference between TRT side effects from injectables versus cream or oral? Injectables produce larger peak-to-trough hormone swings, which drive higher rates of hematocrit elevation, estradiol spikes (and gynecomastia), and mood fluctuation between doses. Daily-application formulations — cream or oral Kyzatrex — maintain more stable blood levels and produce lower rates of polycythemia and estradiol-related side effects. Injection-site reactions (pain, bruising, nodules) are injection-specific. Transfer risk — inadvertently passing testosterone to a partner or child through skin contact — is specific to topical gels and creams; Male Excel's compounded cream format specifically addresses this through low-residue application protocols. See Oral Testosterone vs Injections: Which Is Right for You? for a full side-by-side.

Can TRT worsen sleep apnea? Yes, in susceptible men. Testosterone stimulates upper airway muscles and alters central respiratory drive, and men with existing untreated sleep apnea are at increased risk of apnea exacerbation on TRT. The clinical standard is to screen for sleep apnea symptoms before starting treatment — excessive snoring, daytime fatigue, waking unrefreshed — and to refer for a sleep study if any are present. Sleep apnea is also a contributor to low T itself (via chronic sleep deprivation suppressing testosterone pulses), so treating it before or alongside TRT is often productive.

Do younger men get worse TRT side effects than older men? Not intrinsically — the same side effects apply at any age, governed by dose and genetics, not age. However, younger men (under 35) are more likely to have secondary hypogonadism (a correctable upstream cause) rather than primary hypogonadism, meaning TRT may suppress natural production that could be restored by addressing root causes (sleep, obesity, medication). Younger men also face a longer cumulative exposure window for fertility suppression. Enclomiphene is often a preferable first step for men under 35 who want to preserve fertility and HPT axis function.

Top picks · Related reading

• Male Excel Review: Needle-Free Daily Cream TRT ($149/mo)
• Try Ageless Review: 4 TRT Modalities, Anastrozole Included ($129/mo)
• Oral Testosterone vs Injections: Which Is Right for You?
• TRT Without Needles: Cream vs Oral Testosterone (2026)
• Testosterone Shortage 2026: Needle-Free Workarounds
• Is MangoRx Legit? An Honest Look at the TRT Clinic
• Compare all online TRT clinics →

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. All decisions about hormone therapy should be made with a licensed US physician or nurse practitioner who has reviewed your lab results and health history. Some links in this article are affiliate links; commissions never influence our editorial scores or rankings.